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Background: Global and Basal Longitudinal strain (GLS/BLS) as assessed 
using two- dimensional speckle- tracking imaging have been proposed as subtle 
marker of left ventricular (LV) systolic dysfunction with promising prognostic 
values in asymptomatic patients with aortic stenosis (AS). However, the rela-
tionship between longitudinal strain and symptoms remained unclear. 
Methods: GLS and BLS were measured in 171 patients with pure, isolated, 
and at least mild AS prospectively enrolled at two institutions. We divided 
our population into 4 groups: asymptomatic non- severe AS (N=55), asympto-
matic severe AS with preserved LV ejection fraction (LVEF) (N=37), symp-
tomatic severe AS with preserved LVEF (N=60) and severe AS with reduced 
LVEF (<50%) (N=19).
Results: GLS was signi¿ cantly different among the 4 groups (p<0.0001) 
but the difference was mainly due to patients with reduced LVEF. In addition, 
there was an important overlap between groups and in multivariate analysis, 
after adjustment for age, gender, AS severity and LVEF, GLS was not an inde-
pendent predictor of symptoms (p>0.07). BLS was also signi¿ cantly different 
between the 4 groups (p<0.0001) but in contrast to GLS, BLS was an inde-
pendent predictor of symptoms (p<0.01). However, as for GLS, there was an 
important overlap and differences between groups were close to intra- or inter- 
observer variability (1.3±1.1% and 2.0±1.6% respectively). 
Conclusions: BLS but not GLS was independently associated with the 
symptomatic status. However, there was an important overlap between groups 
and differences were close to measurements’ reproducibility raising caution 
regarding the use of longitudinal strain in the decision- making process of 
patients with severe AS.
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Incidence, predictors and impact of bleeding after transcatheter aortic 
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Background and objective: Bleeding post- PCI is associated with increased 
in- hospital mortality and adverse outcomes. Data regarding the determinants 
and outcomes of bleeding after transcatheter aortic valve implantation (TAVI) 
are limited. We assessed the incidence, predictors and clinical impact of blee-
ding after TAVI in patients from a single center registry.
Methods:  We included 250 consecutive patients implanted in our center 
between May 2006 and October 2011. All procedures were performed using 
the balloon expandable Edwards SAPIEN and SAPIEN XT valves, via trans-
femoral (TF) and transapical (TA) approach. Introducers of 22 and 24 F or 
surgical cutdown were used for TF access when implanting the SAPIEN 
valve, while SAPIEN XT valve was implanted using 18 and 19F sheaths and 
percutaneous closure. The Ascendra 1, 28F and 2, 26F systems were used 
for TA access. Dual antiplatelet therapy was administered preprocedurally in 
TF cases, aspirin only in TA cases, with 70 UI/kg of unfractionated heparin 
after sheath insertion. Life- threatening (LTB), major, minor bleeding and other 
complications were de¿ ned using VARC criteria. 
Results: TAVI was performed via TF access in 190 (76%) cases, and the 
SAPIEN XT model was used in 123 (49.2%) cases. Bleeding after TAVI was 
observed in 68 (27.2%) patients as follows: LTB in 33 (13.2%), major blee-
ding in 23 (9.2%) and minor bleeding in 12 (4.8%). After multivariate ana-
lysis, only TA access was an independent predictor of LTB (OR 3.35, 95% 
CI: 1.52 – 7.38,p<0.003). Patients presenting LTB post- TAVI had a higher 
30- day mortality: 33.3% vs. 3.7%, p<0.001 and 1- year mortality: 46% vs. 
82%,p < 0.001. LTB was an independent predictive factor for 30- day (OR 
6.98, 95% CI: 1.93 – 25.1,p=0.003) and 1- year mortality (HR 2.18, 95% CI: 
1.11 – 4.28,p=0.024).
Conclusion: Bleeding represents a frequent complication of TAVI, being 
observed in over 25% of cases in this single center registry. It is associated 
with higher 30- day and 1 year mortality.
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Background: Previous studies have reported inconsistencies between echo-
cardiographic parameters of severity in aortic valve stenosis (AVS). Peak 
aortic valve velocity (AV- vel) is a robust and reproducible method to estimate 
the severity of AVS and has been strongly validated against prognosis in AVS 
patients. Hence, the present study was conducted to re¿ ne the cut- off values 
of echocardiographic indices of severity to predict an AV- vel 3, 4, and 5m/s 
in AVS patients with normal À ow (stroke volume index>35mL/m2) and pre-
served LV ejection fraction (LV EF>0.50).
Methods and results: We retrospectively reviewed the echocardiography 
charts of 528 consecutive patients (AV- vel 2m/s) referred to our echo lab 
during a 64- months period. LV systolic dysfunction (LV EF<0.50), and para-
doxical low À ow severe AVS (LV EF0.50, AVA1.0cm2 and stroke volume 
index35mL/m2) were exclusion criteria. Mean age was 74±11 year- old and 
55% patients were male. An AVA of 1.0cm2 correlated to a mean pressure gra-
dient (MPG) of 30mmHg and an AV- vel of 3.5m/s. ROC analyses identi¿ ed 
an AVA of 0.9cm2 (accuracy 0.96), an indexed AVA of 0.47cm2/m2 (accuracy 
0.96), a MPG of 39mmHg (accuracy 0.99) and a permeability index (PI) of 
0.27 (accuracy 0.96) as best cut- off values to predict an AV- vel 4m/s. An 
AV- vel 3m/s correlated with an AVA of 1.15cm2, an indexed AVA of 0.60cm2/
m2, a MPG of 22mmHg and a PI of 0.33. Very severe AVS (AV- vel 5m/s) 
was at best predicted by an AVA of 0.76cm2, an indexed AVA of 0.41cm2/m2, 
a MPG of 60mmHg and a PI of 0.22.
Conclusions: The present study con¿ rms inconsistencies between echocar-
diographic parameters of AVS in patients with normal À ow and preserved LV 
EF. The results of the present study may help to re¿ ne the cut- off values of 
AVA and indexed AVA to de¿ ne severe normal À ow AVS.
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Background: The prevention of irreversible myocardial damage is a 
leading challenge in developing future recommendations for the treatment of 
aortic valve stenosis (AS). 
Aim: We sought to evaluate the effects of aortic valve replacement (AVR) 
on left ventricular (LV) longitudinal function and to assess the determinants of 
persistent myocardial dysfunction after AVR. 
Method: Sixty- two consecutive patients who were initially considered 
asymptomatic but who had severe AS were investigated by echocardiography. 
These patients were subsequently operated on for AVR and were reevaluated 
more than 24 months later by echocardiography.
Results: Pre- operatively, left ventricular ejection fraction (LVEF) was 
63±11%, functional aortic valve area was 0.8±0.1cm², LV- global longitu-
dinal strain (GLS) was - 15±3%, and LV mass was 134±40g/m². The post- 
operative control was performed 35±9 months after aortic valve replacement. 
Postoperatively, LVEF was unchanged (64±10%, NS), GLS (- 17±4%, p <0.01) 
increased, and left ventricular mass was 104±34g/m² (p<0.001).  Contractile 
reserve measured using the GLS was associated with greater improvement 
of GLS after AVR (- 4±3±5% vs. 0, p<0.05).  Also, an increase in functional 
aortic valve area of >0.1cm² during exercise was the best predictive criterion 
of a longitudinal strain [- 17%] post- operatively, with an AUC of 0.72, a sen-
sitivity of 0.60, and a speci¿ city of 0.76 (p <0.001). 
Conclusion: Aortic valve compliance and contractile reserve (using “rest to 
exercise” change in GLS) are two important determinants of a persistent myo-
cardial dysfunction after AVR.
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Subclinical left ventricular diastolic dysfunction in asymptomatic pa-
tients with moderate aortic stenosis
Thouraya Filali [Orateur], Houwaida Mahfoudhi, Dhaker Lahidheb, Mehdi 
Gommidh, Badii Jedaida, Nadhem Hajlaoui, Rana Dahmani, Imene Saaidi, 
Abdedayem Hagui, Wafa Fehri, Habib Haouala
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Aim: Left ventricular (LV) diastolic dysfunction is common in severe aortic 
stenosis. The purpose of this study is to evaluate left ventricular (LV) diastolic 
function in asymptomatic patients with moderate aortic stenosis. Moderate 
aortic stenosis (AS) is de¿ ned by a valve area between 1 and 1.5cm². 
Materials and methods: The study population consisted of 30 asympto-
matic patients with isolated moderate aortic valve stenosis (mean aortic valve 
area=1.26±0.2cm²) and 33 age- and sex- matched control subjects. All included 
subjects had no evidence of hypertension, diabetes mellitus, ischemic heart 
diseases or chronic pulmonary diseases. Conventional echocardiography and 
tissue Doppler imaging (TDI) analysis were performed in all patients and 
healthy controls.
Results: LV ejection fraction, the Tei index and the mitral annulus sys-
tolic velocities measured by TDI were similar in both groups. However, mitral 
annulus early diastolic velocities (Em) measured by TDI were markedly reduced 
in patients with moderate AS (7.2±1.1cm/s vs. 12.7±1.8cm/s, p<0.01) with 
higher ratio of early diastolic transmitral pulsed Doppler E to Em (E/Em) velo-
cities (14.5±1.7 vs. 8.6±1.5, p<0.01) suggesting impaired diastolic function.
Conclusion: In the presence of normal systolic function, diastolic LV func-
tion may deteriorate in asymptomatic patients with isolated moderate aortic 
stenosis. Tissue Doppler imaging may provide a useful tool to detect early 
subclinical LV diastolic dysfunction.
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The additional impact of concomitant aortic regurgitation on mid and 
long- term outcome after surgical aortic valve replacement in patients 
with severe aortic stenosis
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Background: Prognostic value of concomitant aortic regurgitation (AR) in 
patients operated for severe aortic stenosis (AS) is not clari¿ ed. 
Purposes: The purpose of this work is the study of the additional impact 
of concomitant AR in patients operated for severe AS on mid and long- term 
results with clinical and echocardiographic follow- up of 20±14 months.
Materials and methods: Our study is retrospective enrolling 70 patients, 
hospitalized in the cardiology department between January 2004 and January 
2011 who bene¿ ted from an Aortic valve replacement. Patients were divided 
according to the preoperative presence and severity of concomitant AR into 
group A with AS without AR or with moderate AR and group B with AS and 
moderate or severe AR.
Results: 40 patients were with AS and moderate or severe AR (57%), 
75% were woman. The mean age was 50+- 8years. The total operative mor-
tality was 5%. NYHA class was improved in all patients. Patients in group 
B experienced decrease in LV volume indices and LV mass index. However 
Mean LVEF remained unchanged. At a mean follow- up of 20±14 months 
6 asymptomatic patients became symptomatic and the total mortality was 
10%. The Comparison between the both groups showed that patients in 
group B were signi¿ cantly older and had more frequently hypertension. 
They had also signi¿ cantly higher LV volume indices and were more likely 
to have left atrial enlargement than patients in group A. In our study patients 
in group A did not have postoperative decrease in LV volume indices, in 
contrast with group B. During 20±14 months of follow- up NYHA class 
remained improved in all patients in group A. Finally the preoperative pre-
sence of severe concomitant AR was not signi¿ cantly related to hospital 
mortality. 
Conclusion: In conclusion, our data indicate that the preoperative presence 
and severity of concomitant AR has no inÀ uence on long- term postoperative 
outcome and LV function in patients undergoing AVR for severe AS.
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plantation using exclusive conscious sedation and local anesthesia with 
the Edwards Sapien and Edwards Sapien XT prosthesis
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Godin (1), Christophe Tron (1), Karim Bejar (1), Carlos Sanchez- Giron (1), 
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Objective: We report in this prospective, single- center study the early 
safety and ef¿ cacy of transfemoral aortic valve implantation (TAVI) using the 
Edwards Sapien (ES) and Sapien XT (SXT) prosthesis, all implanted with 
conscious sedation and local anesthesia, without transesophageal echocardio-
graphy (TEE).
Methods: Between May 2006 and October 2011, 190 consecutive high- 
risk patients with severe aortic stenosis (LogEuroSCORE:21.9±11.9%) unde-
rwent TAVI (ES:n=78.41, 1%;SXT:n=112.59, 9%) under conscious sedation: 
Midazolam 1- 2mg and Nalbuphine 5mg. 30- day primary end- point was a 
combination of all- cause mortality, major stroke, life- threatening bleeding, 
acute kidney injury (AKI) stage 3, peri- procedural myocardial infarction (MI), 
major vascular complication, and repeat- procedure for valve- related dys-
function, according to the Valve Academic Research Consortium endpoints 
(VARC) de¿ nitions. 
Results: Arterial access consisted in surgical cutdown (ES: 100%), or 
percutaneous approach (SXT:98.2%) with preclosing, and was well tole-
rated in all cases. Conversion to general anesthesia (GA) was required in 
only 7 patients (3.2%), (ES:n=5,SXT:n=2) and was related to complications. 
Vasopressors were required in 11 patients (5.8%). Procedural success was 
92.1%. Combined- safety end- point was reached in 31 (16.3%) patients, inclu-
ding overall mortality (6.3%), major stroke (2.1%), life- threatening bleeding 
(8.9%), AKI stage 3 (0.5%), peri- procedural MI (2.1%), major vascular com-
plication (7.9%), and repeat- procedure for valve- related dysfunction (1.6%) at 
30 days. Permanent pacemaker was required in 5.9%. Vascular complications 
required urgent vascular surgery in 7 cases (3.7%), (ES:n=4;SXT:n=3),covered 
stent in 12 (10.8%), all in the SXT group.
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Conclusions: This registry shows the feasibility and safety of transfemoral 
TAVI without GA and TEE in high- surgical- risk patients with severe AS. 
Conversion to GA is low, under 1% with the SXT model.
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Calci¿ c aortic valve stenosis (CAVS) is the most frequent heart valve 
disease, but despite its high incidence this late- onset disease is still poorly 
understood and the only therapy is surgical valve replacement. Although 
CAVS is likely to be a complex disease under the inÀ uence of genetic poly-
morphisms (e.g. in APOB, IL10) and risk factors (e.g. hypertension and cho-
lesterol levels), the identi¿ cation of rare genetic variants with a strong effect 
would give major insights into the mechanisms leading the bone- like pheno-
type. Mutations in the NOTCH1 gene have been linked to aortic valve calci-
¿ cation but they are generally associated with congenital anomalies such as 
bicuspid aortic valves. Our aim is to uncover the ¿ rst genes involved in “dege-
nerative” CAVS occurring on normal tricuspid aortic valves, using recently 
identi¿ ed families which appear to be monogenic autosomal dominant forms 
of CAVS, including a very large pedigree of 48 affected patients.
We sequenced the whole- exome of 20 patients with severe CAVS (from 9 
families with 3 affected patients) using the Illumina HiSeq technology, pro-
viding a mean depth of 82X per patient on average, around 90% of the tar-
geted sequence being covered by at least 10 reads. The hundreds of rare single 
nucleotide variants and indels (allele frequency <1% in controls) are priori-
tised according to their functional consequence, their occurrence in genes in 
inÀ ammatory, osteogenesis, angiogenesis and lipid pathways, and their segre-
gation with the CAVS phenotype in the families. New candidate genes identi-
¿ ed by this study will be screened in a large cohort of already recruited CAVS 
cases to further demonstrate their implication. 
The identi¿ cation of the ¿ rst genetic variants with a strong effect within this 
project could lead to the possibility of alternative patient management for a 
disease that represents a major public health problem in the ageing population.
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Geriatric assessment in patients undergoing transcatheter aortic valve 
implantation
Segolene Rouf¿ ac [Orateur], Bogdan Borz, Philippe Chassagne, Hélène 
Eltchaninoff
CHU CHARLES NICOLLE, Rouen, France
Background: Transcatheter aortic valve implantation (TAVI) is a new 
alternative therapy for inoperable or high risk symptomatic patients (Pts) with 
severe aortic stenosis. However, in elderly Pts optimal management of aortic 
valve depends on dependence and autonomy improvement.
The aim of our study was to evaluate changes in geriatrics autonomy and 
dependence using speci¿ c geriatric scores in Pts undergoing TAVI.
Methods:  From June 2010 to June 2011, 56 patients (23 males) were pros-
pectively included. Mean age was 84.6 years (range 73- 92 years) and mean 
logistic EuroSCORE was 20.4±2.8%. Valve prosthesis (Edwards Sapien/
Sapien XT) was implanted using trans- femoral approach in 44 (78%) or tran-
sapical approach in others. Geriatric assessment using the following scores 
was performed before implantation and at 3 and 6- month after TAVI: Geriatric 
Depression Scale (GDS), Mini Mental State Examination (MMSE), Activities 
of daily Living (ADL) and Instrumental Activities of daily Living (IADL).
Results: TAVI was successfully performed in 53 (95%) Pts. At 6 month, 
survival rate was 81% and there was a marked improvement in hemody-
namics and symptoms. On echocardiography, mean gradient had decreased 
from 48±18 to 9.8±0.7mmHg, (P<0.01); aortic valve area had increased from 
0.7±0.08 to 1.8±0.29cm², (P<0.01) and there was a signi¿ cant change in New 
York Heart Association class (from 2.7±0.5 to 1.4±0.6, P<0.01). 
There was no signi¿ cant changes in autonomy and dependence scores 
at 3 and 6- month for ADL (5.3±1.4 vs 5.3±0.7, p=0.19); IADL (5.2±2.2 vs 
4.8±2.4, p=0.29); MMSE (23.7±4.4 vs 22.9±4.2, p=0.37); GDS (0.8±1.2 vs 
1.3±1.3, p=0.14). 
Conclusion: Our results demonstrate a marked and signi¿ cant clinical 
bene¿ t of TAVI at 6 month with no changes in autonomy and dependance in 
Pts with severe symptomatic aortic valve stenosis.
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Did the decrease in sheath size for transfemoral aortic valve implanta-
tion reduce vascular complications?
Alexandre Canville [Orateur] (1), Christophe Tron (1), Bogdan Borz (1), 
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Litzler (2), Jean- Paul Bessou (2), Alain Cribier (1), Hélène Eltchaninoff (1)
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Chirurgie cardiaque, Rouen, France
Background: Vascular complications are frequent and remain a recognized 
limitation of transcatheter aortic valve implantation (TAVI), associated with 
increased morbidity and mortality. Whether the recent reduction in sheath size 
has led to a decrease in vascular complications is unknown.
Methods: Since May 2006, 250 consecutive patients underwent TAVI with 
the Edwards SAPIEN prosthesis in our institution using either the transfe-
moral (TF, n=190), or the transapical (TA, n=60) approach. Suitability for TF 
was based on ilio- femoral angiography and computed tomography of the ilio-
femoral access. Up to October 2009, TF Edwards SAPIEN (ES) implantation 
required 22 or 24F sheath, inserted surgically in 100% of cases, whereas the 
SAPIEN XT (SXT) prosthesis was compatible with reduced sheath size of 18 
or 19F inserted percutaneously with pre- closure (Prostar XL, 10F) in 98% of 
cases. The consequences on vascular complication are reported according to 
the VARC classi¿ cation. 
Results: TF TAVI was performed using ES prosthesis in 78 pts and SXT in 
112 pts. All baseline characteristics were similar in the two populations, except 
the Log EuroSCORE, lower in the SXT cohort (18.4 vs 27.7%, p<0.0001). 
The ilio- femoral minimal lumen diameter was signi¿ cantly smaller in the SXT 
group (7.1±1.1 vs 8.8±1.3mm, p<0.04). There was no difference in the rate of 
major vascular complications (ES: 7.7% vs SXT: 8.1%) whereas incidence 
of minor vascular complications was higher in the SXT cohort (18.9 vs 9%, 
p<0.05). Vascular complications required urgent vascular surgery in 7 cases 
(3.7%), (ES: n=4; SXT: n=3), and covered stent in 12 (10.8%, all in the SXT 
group). Interestingly, the rate of TA TAVI signi¿ cantly decreased from 37% in 
the ES era to 8.9% after onset of the SXT prosthesis (p<0.05).
Conclusions: The reduced sheath size used for SAPIEN XT implantation 
did not decrease the risk of major vascular complications after TF TAVI but 
increased the rate of minor vascular complications. However, smaller sheath 
sizes allowed with the SAPIEN XT prosthesis has turned TF TAVI into in a 
true percutaneous procedure feasible in smaller iliofemoral vessels, thus redu-
cing markedly the indication for TA TAVI.
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